Roles of Spatial Parameters on the Oscillation of Nuclear NF-κB: Computer Simulations of a 3D Spherical Cell

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ohshima, Daisuke ^a   Inoue, Jun ichiro ^a   Ichikawa, Kazuhisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CELL COMPARTMENTALIZATION; CELLULAR PARAMETERS; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOPLASM; DIFFUSION COEFFICIENT; HIGH FREQUENCY OSCILLATION; MATHEMATICAL MODEL; NUCLEAR PORE COMPLEX; NUCLEAR TO CYTOPLASMIC VOLUME RATIO; OSCILLATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SIMULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; CELL SHAPE; COMPUTER SIMULATION; CYTOPLASM; DIFFUSION; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; MODELS, BIOLOGICAL; NF-KAPPA B; TIME FACTORS;

EID: 84867091567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046911     Document Type: Article

References (67)

1. Kim HJ, Hawke N, Baldwin AS, (2006) NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Differ 13: 738-747.
2. Zhou A, Scoggin S, Gaynor RB, Williams NS, (2003) Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference. Oncogene 22: 2054-2064.
3. Lin Y, Bai L, Chen W, Xu S, (2010) The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 14: 45-55.
4. Karin M, Cao Y, Greten FR, Li ZW, (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
5. Kobayashi T, Kageyama R, (2009) Dynamic advances in NF-kappaB signaling analysis. Sci Signal 2: pe47.
6. Moss BL, Gross S, Gammon ST, Vinjamoori A, Piwnica-Worms D, (2008) Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling. J Biol Chem 283: 8687-8698.
7. Inoue J, Gohda J, Akiyama T, Semba K, (2007) NF-kappaB activation in development and progression of cancer. Cancer Sci 98: 268-274.
8. Hymowitz SG, Wertz IE, (2010) A20: from ubiquitin editing to tumour suppression. Nat Rev Cancer 10: 332-341.
9. Chen ZJ, (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758-765.
10. Bakkar N, Guttridge DC, (2010) NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev 90: 495-511.
11. Perkins ND, (2006) Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730.
12. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
13. Viatour P, Merville MP, Bours V, Chariot A, (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30: 43-52.
14. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
15. Carpenter S, O'Neill LA, (2009) Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J 422: 1-10.
16. Scheidereit C, (2006) IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685-6705.
17. Yamazaki K, Gohda J, Kanayama A, Miyamoto Y, Sakurai H, et al. (2009) Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. SciSignal 2: ra66.
18. Jeong E, Lee JY, (2011) Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J 52: 379-392.
19. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, et al. (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 103: 18154-18159.
20. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W, (1999) IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-30356.
21. Zandi E, Chen Y, Karin M, (1998) Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 281: 1360-1363.
22. Ben-Neriah Y, (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3: 20-26.
23. Hoffmann A, Levchenko A, Scott ML, Baltimore D, (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245.
24. Ashall L, Horton CA, Nelson DE, Paszek P, Harper CV, et al. (2009) Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science 324: 242-246.
25. Sung MH, Salvatore L, De Lorenzi R, Indrawan A, Pasparakis M, et al. (2009) Sustained oscillations of NF-kappaB produce distinct genome scanning and gene expression profiles. PLoS One 4: e7163.
26. Lahav G, (2004) The strength of indecisiveness: oscillatory behavior for better cell fate determination. Sci STKE 2004: pe55.
27. Zhang XP, Liu F, Wang W, (2011) Two-phase dynamics of p53 in the DNA damage response. Proc Natl Acad Sci U S A 108: 8990-8995.
28. Lipniacki T, Paszek P, Brasier AR, Luxon B, Kimmel M, (2004) Mathematical model of NF-kappaB regulatory module. J Theor Biol 228: 195-215.
29. Kearns JD, Basak S, Werner SL, Huang CS, Hoffmann A, (2006) IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol 173: 659-664.
30. Shih VF, Kearns JD, Basak S, Savinova OV, Ghosh G, et al. (2009) Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proc Natl Acad Sci U S A 106: 9619-9624.
31. Witt J, Barisic S, Schumann E, Allgower F, Sawodny O, et al. (2009) Mechanism of PP2A-mediated IKK beta dephosphorylation: a systems biological approach. BMC Syst Biol 3: 71.
32. Park SG, Lee T, Kang HY, Park K, Cho KH, et al. (2006) The influence of the signal dynamics of activated form of IKK on NF-kappaB and anti-apoptotic gene expressions: a systems biology approach. FEBS Lett 580: 822-830.
33. O'Dea EL, Kearns JD, Hoffmann A, (2008) UV as an amplifier rather than inducer of NF-kappaB activity. Mol Cell 30: 632-641.
34. Werner SL, Barken D, Hoffmann A, (2005) Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309: 1857-1861.
35. Ihekwaba AE, Broomhead DS, Grimley R, Benson N, White MR, et al. (2005) Synergistic control of oscillations in the NF-kappaB signalling pathway. Syst Biol (Stevenage) 152: 153-160.
36. Joo J, Plimpton S, Martin S, Swiler L, Faulon JL, (2007) Sensitivity analysis of a computational model of the IKK NF-kappaB IkappaBalpha A20 signal transduction network. Ann N Y Acad Sci 1115: 221-239.
37. Kim D, Kolch W, Cho KH, (2009) Multiple roles of the NF-kappaB signaling pathway regulated by coupled negative feedback circuits. FASEB J 23: 2796-2802.
38. Lipniacki T, Puszynski K, Paszek P, Brasier AR, Kimmel M, (2007) Single TNFalpha trimers mediating NF-kappaB activation: stochastic robustness of NF-kappaB signaling. BMC Bioinformatics 8: 376.
39. Hayot F, Jayaprakash C, (2006) NF-kappaB oscillations and cell-to-cell variability. J Theor Biol 240: 583-591.
40. Lipniacki T, Paszek P, Brasier AR, Luxon BA, Kimmel M, (2006) Stochastic regulation in early immune response. Biophys J 90: 725-742.
41. Tay S, Hughey JJ, Lee TK, Lipniacki T, Quake SR, et al. (2010) Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature 466: 267-271.
42. Krishna S, Jensen MH, Sneppen K, (2006) Minimal model of spiky oscillations in NF-kappaB signaling. Proc Natl Acad Sci U S A 103: 10840-10845.
43. Goodwin BC, (1965) Oscillatory Behavior in Enzymatic Control Processes. AdvEnzymolReg 3: 425-438.
44. Mahaffy JM, Pao CV, (1984) Models of genetic control by repression with time delays and spatial effects. J Math Biol 20: 39-57.
45. Terry AJ, Chaplain MA, (2011) Spatio-temporal modelling of the NF-kappaB intracellular signalling pathway: the roles of diffusion, active transport, and cell geometry. J Theor Biol 290: 7-26.
46. Swaminathan R, Hoang CP, Verkman AS, (1997) Photobleaching recovery and anisotropy decay of green fluorescent protein GFP-S65T in solution and cells: cytoplasmic viscosity probed by green fluorescent protein translational and rotational diffusion. Biophys J 72: 1900-1907.
47. Partikian A, Olveczky B, Swaminathan R, Li Y, Verkman AS, (1998) Rapid diffusion of green fluorescent protein in the mitochondrial matrix. J Cell Biol 140: 821-829.
48. Dayel MJ, Hom EF, Verkman AS, (1999) Diffusion of green fluorescent protein in the aqueous-phase lumen of endoplasmic reticulum. Biophys J 76: 2843-2851.
49. Miyawaki A, (2011) Proteins on the move: insights gained from fluorescent protein technologies. Nat Rev Mol Cell Biol 12: 656-668.
50. Biteen JS, Moerner WE, (2010) Single-Molecule and Superresolution Imaging in Live Bacteria Cells. Cold spring Harvor Perspectives in Biology pp. a000448.
51. Fusco D, Accornero N, Lavoie B, Shenoy SM, Blanchard JM, et al. (2003) Single mRNA molecules demonstrate probabilistic movement in living mammalian cells. Curr Biol 13: 161-167.
52. Jorgensen P, Edgington NP, Schneider BL, Rupes I, Tyers M, et al. (2007) The size of the nucleus increases as yeast cells grow. Mol Biol Cell 18: 3523-3532.
53. Huber MD, Gerace L, (2007) The size-wise nucleus: nuclear volume control in eukaryotes. J Cell Biol 179: 583-584.
54. Neumann FR, Nurse P, (2007) Nuclear size control in fission yeast. J Cell Biol 179: 593-600.
55. Millot C, Dufer J, (2000) Clinical applications of image cytometry to human tumour analysis. Histol Histopathol 15: 1185-1200.
56. Pienta KJ, Coffey DS, (1991) Correlation of nuclear morphometry with progression of breast cancer. Cancer 68: 2012-2016.
57. Katsoulis M, Lekka J, Vlachonikolis I, Delides GS, (1995) The prognostic value of morphometry in advanced epithelial ovarian cancers. Br J Cancer 72: 958-963.
58. Salmon I, Kiss R, Franc B, Gasperin P, Heimann R, et al. (1992) Comparison of morphonuclear features in normal, benign and neoplastic thyroid tissue by digital cell image analysis. Anal Quant Cytol Histol 14: 47-54.
59. Montironi R, Scarpelli M, Sisti S, Braccischi A, Mariuzzi GM, (1990) Morphological and quantitative analyses of intraductal dysplasia of the prostate. Anal Cell Pathol 2: 277-285.
60. Xu S, Powers MA, (2009) Nuclear pore proteins and cancer. Semin Cell Dev Biol 20: 620-630.
61. Martinez N, Alonso A, Moragues MD, Ponton J, Schneider J, (1999) The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res 59: 5408-5411.
62. Tokuda N, Terada TP, Sasai M, (2012) Dynamical modeling of three-dimensional genome organization in interphase budding yeast. Biophys J 102: 296-304.
63. Cho K, Shin S, Kolch W, Wolkenhauer O, (2003) Experimental Design in Systems Biology, Based on Parameter Sensitivity Analysis Using a Monte Carlo Method: A Case Study for the TNFα-Mediated NF-κB Signal Transduction Pathway. Simulation 79: 726-739.
64. Barken D, Wang CJ, Kearns J, Cheong R, Hoffmann A, et al. (2005) Comment on "Oscillations in NF-kappaB signaling control the dynamics of gene expression". Science 308: 52; author reply 52.
65. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, et al. (2004) Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306: 704-708.
66. Ichikawa K, (2001) A-Cell: graphical user interface for the construction of biochemical reaction models. Bioinformatics 17: 483-484.
67. Ichikawa K, (2005) A modeling environment with three-dimensional morphology, A-Cell-3D, and Ca2+ dynamics in a spine. Neuroinformatics 3: 49-64.